VERITON PHARMA LIMITED

Active Weybridge

Wholesale of pharmaceutical goods

26 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods
V

VERITON PHARMA LIMITED

Wholesale of pharmaceutical goods

Founded 21 Jan 1997 Active Weybridge, United Kingdom 26 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods

Previous Company Names

SPECIAL PRODUCTS LIMITED 21 Jan 1997 — 29 Sept 2017
Accounts Submitted 10 Apr 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 18 Feb 2026 Next due 4 Feb 2027 9 months remaining
Net assets £11M £4M 2024 year on year
Total assets £18M £4M 2024 year on year
Total Liabilities £7M £583K 2024 year on year
Charges 3
3 satisfied

Contact & Details

Contact

Registered Address

Unit 16 Trade City Avro Way Brooklands Business Park Weybridge Surrey KT13 0YF

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for VERITON PHARMA LIMITED (03305136), an active life sciences and medical technology company based in Weybridge, United Kingdom. Incorporated 21 Jan 1997. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

£7.89M

Increased by £3.03M (+62%)

Net Assets

£11.24M

Increased by £3.78M (+51%)

Total Liabilities

£6.50M

Increased by £583.00k (+10%)

Turnover

£21.52M

Increased by £2.16M (+11%)

Employees

26

Debt Ratio

37%

Decreased by 7 (-16%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Sawdon, Brindley AlexanderDirectorBritishUnited Kingdom3730 Jun 2023Active

Shareholders

Shareholders (2)

Serb Ltd
100.0%
1,090,000
March Medical Limited
0.0%
0

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Serb Ltd

Unknown

Active
Notified 11 Sept 2025
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent

March Medical Limited

Ceased 11 Sept 2025

Ceased

Group Structure

Group Structure

VERITON PHARMA LIMITED Current Company

Charges

Charges

3 satisfied

Properties

Properties

2 leasehold 2 total
AddressTenurePrice PaidDate Added
Unit 16, Trade City, Avro Way, Brooklands Business Park, Weybridge (KT13 0YF) ELMBRIDGE
Leasehold-29 Jul 2016
Unit 16, Trade City, Avro Way, Brooklands Business Park, Weybridge (KT13 0YF) ELMBRIDGE
Leasehold-1 Oct 2007
Unit 16, Trade City, Avro Way, Brooklands Business Park, Weybridge (KT13 0YF)
Leasehold
Added 29 Jul 2016
District ELMBRIDGE
Unit 16, Trade City, Avro Way, Brooklands Business Park, Weybridge (KT13 0YF)
Leasehold
Added 1 Oct 2007
District ELMBRIDGE

Documents

Company Filings

DateCategoryDescriptionDocument
18 Feb 2026Confirmation StatementConfirmation statement made on 2026-01-21 with updates
16 Feb 2026Persons With Significant ControlSerb Ltd notified as a person with significant control
16 Feb 2026Persons With Significant ControlCessation of March Medical Limited as a person with significant control on 2025-09-11
24 Jun 2025OfficersTermination of Collyer Bristow Secretaries Limited as director on 2025-06-11
10 Apr 2025AccountsAnnual accounts made up to 2024-12-31
18 Feb 2026 Confirmation Statement

Confirmation statement made on 2026-01-21 with updates

16 Feb 2026 Persons With Significant Control

Serb Ltd notified as a person with significant control

16 Feb 2026 Persons With Significant Control

Cessation of March Medical Limited as a person with significant control on 2025-09-11

24 Jun 2025 Officers

Termination of Collyer Bristow Secretaries Limited as director on 2025-06-11

10 Apr 2025 Accounts

Annual accounts made up to 2024-12-31

Recent Activity

Latest Activity

Confirmation statement made on 2026-01-21 with updates

2 months ago on 18 Feb 2026

Serb Ltd notified as a person with significant control

2 months ago on 16 Feb 2026

Cessation of March Medical Limited as a person with significant control on 2025-09-11

2 months ago on 16 Feb 2026

Termination of Collyer Bristow Secretaries Limited as director on 2025-06-11

10 months ago on 24 Jun 2025

Annual accounts made up to 2024-12-31

1 years ago on 10 Apr 2025